Results 251 to 260 of about 3,917,874 (426)

Protein kinase C epsilon activation improves early survival in an acute porcine model of controlled hemorrhage. [PDF]

open access: yesSci Rep
Simchoni M   +15 more
europepmc   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

open access: yesMolecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson   +11 more
wiley   +1 more source

Activation of Distinct Inflammatory Pathways in LR-MDS Is Determined By Genetics

open access: bronze, 2022
M. Schneider   +18 more
openalex   +1 more source

Optimized Gal4 genetics for permanent gene expression mapping in zebrafish

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2009
M. Distel, M. Wullimann, R. Köster
semanticscholar   +1 more source

<i>TFAP2E</i> is implicated in central nervous system, orofacial and maxillofacial anomalies. [PDF]

open access: yesJ Med Genet
Kalanithy JC   +38 more
europepmc   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu   +11 more
wiley   +1 more source

Identification of inhibitors of auxin transcriptional activation by means of chemical genetics in Arabidopsis

open access: green, 2004
Joshua I. Armstrong   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy